Conversations on Mental Health: Sharmin Ghaznavi, MD, PhD, & The Center for the Neuroscience of Psychedelics
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Treats:
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
The center’s mission is to understand how psychedelics enhance the brain’s capacity for change, to optimize current treatments and create new treatments for mental illness and to render the term “treatment resistant” obsolete.